CytomX Therapeutics (CTMX) Provides Business Update and Outlines 2023 Goals

Go back to CytomX Therapeutics (CTMX) Provides Business Update and Outlines 2023 Goals
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 3.41 +0.12 (3.65%)
Previous Close $3.29    52 Week High $24.68 
Open $3.31    52 Week Low $9.10 
Day High $3.42    P/E N/A 
Day Low $3.31    EPS $0.00 
Volume 388,381